[1] Rickert C H, Paulus W. Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification[J]. Childs Nerv Syst, 2001,17(9):503-511.[2] Louis D N, Ohgaki H, Wiestler O D, et al. WHO classification of tumors of the central nervous system[M]. Lyon: I ARC Press, 2007.[3] Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database[J]. Cancer, 2009,115(24):5761-5770.[4] 李俊芝,马遇庆,张巍,等.1629例中枢神经系统肿瘤的临床病理分析[J].中国现代医学杂志,2011,21(16):1910-1913.[5] Liu Q, Liu R, Kashyap M V, et al. Brainstem glioma progression in juvenile and adult rats[J]. J Neurosurg, 2008,109(5):849-855.[6] Merchant T E, Pollack I F, Loeffler J S. Brain tumors across the age spectrum: biology, therapy, and late effects[J]. Semin Radiat Oncol, 2010,20(1):58-66.[7] Hestdal K, Ruscetti F W, Chizzonite R, et al. Interleukin-1(IL-1) directly and indirectly promotes hematopoietic cell growth through type Ⅰ IL-1 receptor[J]. Blood, 1994,84(1):125-132.[8] Subramaniam S, Stansberg C, Cunningham C. The interleukin 1 receptor family[J]. Dev Comp Immunol, 2004,28(5):415-428.[9] Smith D E, Hanna R, Della F, et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type Ⅱ IL-1 receptor to inhibit IL-1 action[J]. Immunity, 2003,18(1):87-96.[10] Livak K J, Schmit tgen T D. Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods, 2001,25(4):402-408.[11] Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvesseldensity and tumour cell proliferation in human epidermoidlung carcinoma[J]. Br J Cancer, 1996,73(3):931-934.[12] 张懋植.成人低级别胶质瘤的治疗进展[J].中国微侵袭神经外科杂志,2006,11(1):1-2.[13] Vecht C J. Effect of age on treatment decisions in low-grade glioma[J]. J Neurol Neurosurg Psychiatry, 1993,56(12):1259-1264.[14] Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma[J]. J Clin Oncol, 2002,20(8):2076-2084.[15] Jubelirer S J, Rubin M, Shim C. An analysis of 38 cases of low-grade cerebral astrocytoma in adults[J]. W V Med J, 1993,89(3):102-105.[16] 孙增峰,李文良,谷峰,等.胶质瘤耐药相关机制的研究进展[J].中华肿瘤防治杂志,2011,18(7):551-556.[17] 朱航,雷迅,张帆,等.脑胶质瘤危险因素Meta分析及危险因素控制后发病率的变化趋势[J].中国医科大学学报,2012,41(6):554-558.[18] Kim H S, Kim M S, Hancock A L, et al. ntification of novel Wilms' tumor suppressor gene target genes implicated in kidneydevelopment[J]. J Biol Chem, 2007,282(22):16278-16287.[19] Järås M, Johnels P, Hansen N, et al. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein[J]. Proc Natl Acad Sci USA, 2010,107(37):16280-16285. |